Bausch Health Cos Operating Income 2012-2026 | BHC
Bausch Health Cos operating income from 2012 to 2026. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
|
Bausch Health Cos Annual Operating Income (Millions of US $) |
|
|---|---|
| 2025 | $1,813 |
| 2024 | $1,546 |
| 2023 | $963 |
| 2022 | $454 |
| 2021 | $450 |
| 2020 | $676 |
| 2019 | $-203 |
| 2018 | $-2,384 |
| 2017 | $102 |
| 2016 | $-566 |
| 2015 | $1,527 |
| 2014 | $2,001 |
| 2013 | $-410 |
| 2012 | $80 |
| 2011 | $300 |
|
Bausch Health Cos Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2026-03-31 | $-950 |
| 2025-12-31 | $474 |
| 2025-09-30 | $619 |
| 2025-06-30 | $444 |
| 2025-03-31 | $276 |
| 2024-12-31 | $558 |
| 2024-09-30 | $318 |
| 2024-06-30 | $389 |
| 2024-03-31 | $281 |
| 2023-12-31 | $362 |
| 2023-09-30 | $14 |
| 2023-06-30 | $412 |
| 2023-03-31 | $175 |
| 2022-12-31 | $-244 |
| 2022-09-30 | $244 |
| 2022-06-30 | $161 |
| 2022-03-31 | $293 |
| 2021-12-31 | $367 |
| 2021-09-30 | $574 |
| 2021-06-30 | $-270 |
| 2021-03-31 | $-221 |
| 2020-12-31 | $-5 |
| 2020-09-30 | $460 |
| 2020-06-30 | $-27 |
| 2020-03-31 | $248 |
| 2019-12-31 | $-1,076 |
| 2019-09-30 | $329 |
| 2019-06-30 | $257 |
| 2019-03-31 | $287 |
| 2018-12-31 | $25 |
| 2018-09-30 | $117 |
| 2018-06-30 | $-245 |
| 2018-03-31 | $-2,281 |
| 2017-12-31 | $-322 |
| 2017-09-30 | $38 |
| 2017-06-30 | $175 |
| 2017-03-31 | $211 |
| 2016-12-31 | $150 |
| 2016-09-30 | $-863 |
| 2016-06-30 | $81 |
| 2016-03-31 | $66 |
| 2015-12-31 | $167 |
| 2015-09-30 | $448 |
| 2015-06-30 | $342 |
| 2015-03-31 | $571 |
| 2014-12-31 | $605 |
| 2014-09-30 | $684 |
| 2014-06-30 | $355 |
| 2014-03-31 | $357 |
| 2013-12-31 | $224 |
| 2013-09-30 | $-892 |
| 2013-06-30 | $142 |
| 2013-03-31 | $117 |
| 2012-12-31 | $-98 |
| 2012-09-30 | $29 |
| 2012-06-30 | $87 |
| 2012-03-31 | $61 |
| 2011-12-31 | $-6 |
| 2011-09-30 | $112 |
| 2011-06-30 | $118 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $2.086B | $10.266B |
| Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $35.437B | 10.97 |
| BridgeBio Pharma (BBIO) | United States | $14.460B | 0.00 |
| Dr Reddy's Laboratories (RDY) | India | $11.109B | 17.29 |
| Aspen Pharmacare (APNHY) | South Africa | $3.708B | 0.00 |
| Supernus Pharmaceuticals (SUPN) | United States | $2.918B | 22.33 |
| Taysha Gene Therapies (TSHA) | United States | $1.290B | 0.00 |
| Amphastar Pharmaceuticals (AMPH) | United States | $0.924B | 7.28 |
| Personalis (PSNL) | United States | $0.630B | 0.00 |
| Assembly Biosciences (ASMB) | United States | $0.451B | 0.00 |
| Sol-Gel Technologies (SLGL) | Israel | $0.210B | 0.00 |
| Metagenomi Therapeutics (MGX) | United States | $0.052B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.019B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |